The effectiveness, safety and epidemiology of the use of acarbose in the treatment of patients with type II diabetes mellitus A model of medicine-based evidence N. ScorpiglioneM. BelfiglioA. Nicolucci CLINICAL TRIALS Pages: 239 - 249
No cardiovascular effects of single-dose pseudoephedrine in patients with essential hypertension treated with β-blockers N. MoresU. CampiaP. Preziosi CLINICAL TRIALS Pages: 251 - 254
Effects of captopril and enalapril on electroencephalogram and cognitive performance in healthy volunteers U. EbertW. Kirch PHARMACODYNAMICS Pages: 255 - 257
Long-term treatment with antipsychotic drugs in conventional doses prolonged QTc dispersion, but did not increase ventricular tachyarrhythmias in patients with schizophrenia in the absence of cardiac disease Hiorki KitayamaKaname KiuchiHirokazu Hayakawa PHARMACODYNAMICS Pages: 259 - 262
The local effects of systemic digoxin on the cutaneous microcirculation M. GrossmannM. J. JamiesonW. Kirch PHARMACODYNAMICS Pages: 263 - 268
The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency T. W. B. GehrD. M. TeneroN. H. Shusterman PHARMACOKINETICS AND DISPOSITION Pages: 269 - 277
Lack of polymorphism of the conversion of losartan to its active metabolite E-3174 in extensive and poor metabolizers of debrisoquine (cytochrome P450 2D6) and mephenytoin (cytochrome P450 2C19) P. SandwallM.-W. LoF. Sjöqvist PHARMACOKINETICS AND DISPOSITION Pages: 279 - 283
Inhibition of thiopurine S-methyltransferase activity by impurities in commercially available substrates: a factor for differing results of TPMT measurements T. KröplinC. FischerH. Iven PHARMACOKINETICS AND DISPOSITION Pages: 285 - 291
Pharmacokinetics and antidiuretic effect of a new vasopressin analogue (F992) in overhydrated male volunteers T. CallréusJ. LundahlP. Höglund PHARMACOKINETICS AND DISPOSITION Pages: 293 - 298
Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease C. ThalamasA. TaylorO. Rascol PHARMACOKINETICS AND DISPOSITION Pages: 299 - 303
Changes in gastrointestinal motility influence the absorption of desmopressin T. CallréusJ. LundahlP. Bengtsson PHARMACOKINETICS AND DISPOSITION Pages: 305 - 309
Lack of a pharmacokinetic interaction between atovaquone and proguanil C. GillotinJ. P. MametL. Veronese PHARMACOKINETICS AND DISPOSITION Pages: 311 - 315
Improved penetration of aminoglycosides and fluoroquinolones into the aqueous humour of patients by means of Acuvue contact lenses E.-M. HehlR. BeckB. Drewelow PHARMACOKINETICS AND DISPOSITION Pages: 317 - 323
“Doi moi” and private pharmacies: a case study on dispensing and financial issues in Hanoi, Vietnam Nguyen Thi Kim ChucGöran Tomson PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 325 - 332
Drug use in patients with atrial fibrillation in Swedish primary health care: a comparison 5 years apart P. E. Wändell PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 333 - 337